| Today's Open | $13.80 |
|---|---|
| Previous Close | $13.79 |
| Daily Range | $13.50 - $14.36 |
| 52-Week Range | $1.30 - $14.75 |
| Market Cap | $1.1B |
| P/E Ratio | -40.56 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 2,829,200 |
| Average Daily Volume | 4,111,309 |
| Current FY EPS | -$0.35 |
Sector
Healthcare
Industry
Drugs
ACADIA Pharmaceuticals, Inc. (ACAD) Description
The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Website: http://www.acadia-pharm.com/
News & Commentary
ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Comple
ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Comple
ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common StockBiotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker B
Plus, there were purchases at Lionbridge Technologies and LivePerson.Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker B
Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker Buys ACADIAACAD's Top Competitors
(2.89%)
(0.27%)
(0.59%)
(1.13%)